CytoMed Therapeutics
GDTC
#8290
Rank
$23.08 M
Marketcap
$2.00
Share price
-1.48%
Change (1 day)
-53.49%
Change (1 year)

CytoMed Therapeutics (GDTC) - P/B ratio

P/B ratio as of July 2024 : 2.71

According to CytoMed Therapeutics's latest financial reports the company has a price-to-book ratio of 2.71.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

CytoMed Therapeutics - P/B ratio (from 2023 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-316.63
2022-12-31N/A
2021-12-31N/A